Full Title
A Phase 1 Study of ASP5834 in Participants with Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies with KRAS Mutations or KRAS AmplificationsPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Wungki Park’s office at 646-888-4543.
Protocol
25-331
Phase
Phase I (phase 1)
Disease Status
Newly Diagnosed & Relapsed/Refractory
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT07094204